DMTR.L Regulatory News (DMTR)

9 January 2017

Cronin Group Plc

("Cronin" or the "Company")

DigitalGlassware™

Cronin Group Plc announces that between the 9th and 12th January 2017 Professor Lee Cronin, Founding Scientific Director, will be attending the 35th Annual J.P. Morgan Healthcare Conference and at which he will be introducing the Company's pathway to its first commercial product to a number of potential partners and key opinion leaders.

During 2017 Cronin Group intends to release prototype and beta versions of a new product platform, branded DigitalGlassware™, which it anticipates will undergo testing and development with a number of collaboration partners. Early product releases of DigitalGlassware™ will be a low-cost, easy to use chemical telemetry product designed to enable the first digitization of chemistry in commercial and academic research laboratories. Eventually the DigitalGlassware™ platform is envisaged to have a range of commercial applications in various target markets, including Healthcare.

Cronin Group's ultimate vision is to commercialise the Chemputer™, an autonomous universal digital synthesis engine, which intends to open up chemistry to a wider user-base via digitization. This will allow chemical synthesis to be flexible and widely accessible irrespective of access to physical infrastructure and chemical knowledge.

ENDS